Abstract
Urinary tract infections (UTIs) are one of the major sources of widespread infectious diseases in the community as well as in the hospitals which increase the cause of morbidity and mortality. Prevalence of extended-spectrum-β-lactamase (ESBL)-producing uropathogenic E. coli isolates has been found to be increased rapidly across the world. The present study was undertaken to find out the frequency of bla TEM, bla CTX-M, and bla SHV genes among E. coli isolates from UTI and detect their sensitivity pattern. A total of 112 non-repeated E. coli isolates obtained from urine samples of UTI diagnosed patients were included in this study. Antibiotic susceptibility test was done by disc diffusion method. Seventy seven (68.75%) isolates were MDR and tested for ESBL. ESBL-positive isolates were screened for bla TEM, bla CTX-M, and bla SHV genes by monoplex PCR (polymerase chain reaction). Among 46 ESBL-producing E. coli isolates, 8.69% harboured all the three bla genes. The bla TEM was the predominant (93.47%) gene followed by bla CTX-M (82.6%) and bla SHV (4.34%). It can be concluded that the prevalence of MDR (multidrug resistance) ESBL-producing E. coli appears to be high and the highest identified gene was bla TEM. The knowledge of resistance pattern can help physician’s select suitable empirical antibiotic regimens, so that antibiotics showing high-resistance pattern can be avoided.
Similar content being viewed by others
References
Abujnah AA, Zorgani A, Sabri MAM et al (2015) Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya. Libyan J Med 10:26412. doi:10.3402/ljm.v10.26412
Adwan K, Jarrar N, Abu-Hijleh A et al (2014) Molecular characterization of Escherichia coli isolates from patients with urinary tract infections in Palestine. J Med Microbiol 63:229–234. doi:10.1099/jmm.0.067140-0
Bagattini M, Crivaro V, Di Popolo A et al (2006) Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 57:979–982. doi:10.1093/jac/dkl077
Bajpai T, Pandey M, Varma M, Bhatambare GS (2017) Prevalence of TEM, SHV and CTX-M beta-lactamase genes in the urinary isolates of a tertiary care hospital. Avicenna J Med 7:12–16
Bali EB, Açık L, Sultan N (2010) Phenotypic and molecular characterization of SHV produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res 4:650–654
Barguigua A, El Otmani F, Talmi M et al (2011) Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol 60:1344–1352. doi:10.1099/jmm.0.032482-0
Bronson JJ, Barrett JF (2001) Quinolone, everninomycin, glycylcycline, carbapenem, lipopeptide and cephem antibacterials in clinical development. Curr Med Chem 8:1775–1793
Carattoli A, García-Fernández A, Varesi P et al (2008) Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases isolated in Rome, Italy. J Clin Microbiol 46:103–108. doi:10.1128/JCM.01542-07
Chaudhary U, Aggarwal R (2004) Extended spectrum β-lactamases (ESBL)-an emerging threat to clinical therapeutics. Indian J Med Microbiol 22:75–80
Daoud Z, Salem Sokhn E, Masri K et al (2015) Escherichia coli isolated from urinary tract infections of Lebanese patients between 2005 and 2012: epidemiology and profiles of resistance. Front Med 2:26. doi:10.3389/fmed.2015.00026
Eckert C, Gautier V, Saladin-Allard M et al (2004) Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249–1255. doi:10.1128/AAC.48.4.1249-1255.2004
El Bouamri MC, Arsalane L, Zerouali K et al (2015) Molecular characterization of extended spectrum β-lactamase-producing Escherichia coli in a university hospital in Morocco, North Africa. Afr J Urol 21:161–166. doi:10.1016/j.afju.2015.02.005
Fernandes R, Amador P, Oliveira C, Prudêncio C (2014) Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal. Sci World J. doi:10.1155/2014/782897
Gonzalez CM, Schae€er AJ (1999) Treatment of urinary tract infection: what’s old, what’s new, and what works. World J Urol 17:372–382. doi:10.1007/s003450050163
Haque SF (2011) Extended spectrum β-lactamases mediated resistance in urinary tract infections “Changing profile at a teaching hospital of north India”. Int J Cur Bio Med Sci 1:103–107
Harada Y, Morinaga Y, Yamada K et al (2013) Clinical and molecular epidemiology of extended spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli in a Japanese tertiary hospital. J Med Microbiol Diagn 2:127
Hassan SA, Jamal SA, Mustafa K (2011) Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections. J Basic Appl Sci 7:39–43
Hosoglu S, Gundes S, Kolayh F et al (2007) Extended spectrum β-lactamases in ceftazidime resistant Escherichia coli and Klebsiella pneumonia isolates in Turkish hospitals. Indian J Med Microb 25:346–350
Hsueh PR, Hoban DJ, Carmeli Y et al (2011) Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 63:114–123. doi:10.1016/j.jinf.2011.05.015
Ibrahim ME, Bilal NE, Magzoub MA, Hamid ME (2013) Prevalence of extended-spectrum β-lactamases-producing Escherichia coli from hospitals in Khartoum State, Sudan. Oman Med J 28:116–120. doi:10.5001/omj.2013.30
Jena J, Debata NK, Subudhi E (2013) Prevalence of extended-spectrum-β-lactamase and metallo-β-lactamase producing multi drug resistance gram-negative bacteria from urinary isolates. Indian J Med Microbiol 31:420–421
Jena J, Sahoo RK, Subudhi E, Debata NK (2014) Prevalence of ESBL, MBL and Ampc-β-lactamases producing multidrug resistance gram negative bacteria in a tertiary care hospital. J Pure Appl Microbiol 8:4099–4105
Manoharan A, Premalatha K, Chatterjee S, Mathai D (2011) Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol 29:161–164. doi:10.4103/0255-0857.81799
Moosavian M, Deiham B (2012) Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran. African J Microbiol Res 6:5433–5439. doi:10.5897/AJMR11.017
Nandagopal B, Sankar S, Sagadevan K et al (2015) Frequency of extended spectrum β-lactamase producing urinary isolates of gram-negative bacilli among patients seen in a multispecialty hospital in Vellore district, India. Indian J Med Microbiol 33:282–285. doi:10.4103/0255-0857.153563
Paterson DL, Bonomo RA (2014) Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18:1–36
Pitout JD, Sanders CC, Sanders WE (1997) Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 103:51–59. doi:10.1016/S0002-9343(97)00044-2
Ponnusamy P, Nagappan R (2015) Molecular characterization of bla CTX-M, bla TEM, bla SHV- beta lactamase produced by uropathogenic Escherichia coli isolates. Int J Microbiol Res 6:67–73
Ramanath KV, Shafiya SB (2011) Prescription pattern of antibiotic usage for urinary tract infection treated in a rural tertiary care hospital. Indian J Pharma Pract 4:57–63
Rezai MS, Salehifar E, Rafiei A et al (2015) Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. Biomed Res Int. doi:10.1155/2015/309478
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Seyedjavadi SS, Goudarzi M, Sabzehali F (2015) Relation between blaTEM, blaSHV and blaCTX-M genes and acute urinary tract infections. J Acute Dis 5:1–6. doi:10.1016/j.joad.2015.07.007
Shahcheraghi F, Nasiri S, Noveiri H (2009) Detection of extended-spectrum β-lactamases (ESBLs) in Escherichia coli, Iran. J Clin Infect Dis 4:65–70
Shahid M, Singh A, Sobia F et al (2011) blaCTX-M, blaTEM, and blaSHV in Enterobacteriaceae from North-Indian tertiary hospital: high occurrence of combination genes. Asian Pac J Trop Med 4:101–105
Sharma M, Pathak S, Srivastava P (2013) Prevalence and antibiogram of extended spectrum β-lactamase (esbl) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 7:2173–2177. doi:10.7860/JCDR/2013/6460.3462
Shigemura K, Arakawa S, Miura T et al (2008) Significance of fluoroquinolone resistant Escherichia coli in urinary tract infections. Jpn J Infect Dis 61:226–228
Tada DG, Gandhi PJ, Patel KN (2012) A study on antibiotic related resistance in UTI patients: a comparison between community acquired and hospital acquired E. coli. Natl J Community Med 3:255–258
Thong KL, Lim KT, Yasin R et al (2009) Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in malaysia. J Biomed Biotechnol. doi:10.1155/2009/165637
Weill FX, Demartin M, Tande D et al (2004) SHV-12 like extended spectrum β-lactamase producing strains of Salmonella enteric serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali. J Clin Microbiol 42:2432–2437
Yu Y, Ji S, Chen Y et al (2007) Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J Infect 54:53–57. doi:10.1016/j.jinf.2006.01.014
Acknowledgements
We are grateful to Prof. Dr. DK Roy, Dean, IMS and Sum Hospital (S‘O’A University) for extended essential laboratory facilities. Our sincere thanks are due to Prof. Dr. M.R. Nayak, Honourable President, Siksha ‘O’ Anusandhan University, Bhubaneswar, for providing financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We declare that we have no conflict of interest.
Rights and permissions
About this article
Cite this article
Jena, J., Sahoo, R.K., Debata, N.K. et al. Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults. 3 Biotech 7, 244 (2017). https://doi.org/10.1007/s13205-017-0879-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-017-0879-2